ALTERATIONS OF HEART DYNORPHIN-A IN THE DEVELOPMENT OF SPONTANEOUSLY HYPERTENSIVE RATS

被引:15
作者
DUMONT, M
SABOURIN, L
LEMAIRE, S
机构
[1] Department of Pharmacology, Faculty of Health Sciences, University of Ottawa, Ottawa
基金
英国医学研究理事会;
关键词
D O I
10.1016/0143-4179(90)90159-V
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In order to investigate the pathophysiological role of heart dynorphin-A (Dyn-A) in genetic hypertension, immunoreactive (ir)-Dyn-A was measured in heart extracts of spontaneously hypertensive rats (SHR) and compared with that of age matched Wistar (WR) and Wistar Kyoto (WKY) rats. Heart ir-Dyn-A contents in 8 week-old WK (84 fmol/g tissue) were not significantly different from those of age matached WKY (109 fmol/g tissue). In control WKY, the levels of ir-Dyn-A did not significantly vary with the age (from 109 to 117 fmol/g) except in 16 week-old animals which displayed a significant increase (238 fmol/g tissue) compared to younger animals. In SHR, the heart content of ir-Dyn-A displayed a 6.5 fold increase at 8 weeks compared to age matched WKY. Older SHR showed a return of their heart ir-Dyn-A content to control (12 week-old) or below control values (16 week-old; 121 compared with 238 fmol/g tissue in WKY). Heart ir-Dyn-A in WKY and SHR eluted as a single peak on μ-vondapak HPLC, corresponding with the retention time of synthetic Dyn-A. A local function for cardiac ir-Dyn-A is suggested by the presence in heart membrane preparations of a high affinity binding site for the κ selective opioid ligand, [3H]U-69593, with KD of 6.4 (WKY) and 8.5 (SHR) nM and Bmax of 3.7 (WKY) and 3.6 (SHR) pmol/g protein. The alterations in the levels of cardiac ir-Dyn-A during the development of hypertension in SHR were analyzed in regard with the reported effects of Dyn-related peptides on heart natriuretic and sympathetic functions. © 1990.
引用
收藏
页码:43 / 48
页数:6
相关论文
共 27 条
  • [1] CHARKIN C, 1982, SCIENCE, V215, P413
  • [2] ASBESTOS-RELATED INCREASE IN PULMONARY LEVELS OF VASOACTIVE INTESTINAL PEPTIDE (VIP)
    DAY, R
    LEMAIRE, I
    MERCIER, P
    BEAUDOIN, H
    LEMAIRE, S
    [J]. LIFE SCIENCES, 1983, 33 (19) : 1869 - 1876
  • [3] INCREASED CONTENT OF IMMUNOREACTIVE LEU-ENKEPHALIN AND ALTERATION OF DELTA-OPIOID RECEPTOR IN HEARTS OF SPONTANEOUSLY HYPERTENSIVE RATS
    DUMONT, M
    LEMAIRE, S
    [J]. NEUROSCIENCE LETTERS, 1988, 94 (1-2) : 114 - 118
  • [4] FEURSTEIN G, 1987, CIRCULATION S1, V75, P1
  • [5] ON THE OPIOID RECEPTOR SUBTYPE INHIBITING THE EVOKED RELEASE OF H-3 NORADRENALINE FROM GUINEA-PIG ATRIA INVITRO
    FUDER, H
    BUDER, M
    RIERS, HD
    ROTHACHER, G
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1986, 332 (02) : 148 - 155
  • [6] CENTRAL AND PERIPHERAL SITES FOR CARDIOVASCULAR ACTIONS OF DYNORPHIN-1(1-13) IN RATS
    GAUTRET, B
    SCHMITT, H
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 111 (02) : 263 - 266
  • [7] GOLDSTEIN A, 1983, PEPTIDES ANAL SYNTHE, V7, P410
  • [8] ANALOGS OF BETA-LPH61-64 POSSESSING SELECTIVE AGONIST ACTIVITY AT MU-OPIATE RECEPTORS
    HANDA, BK
    LANE, AC
    LORD, JAH
    MORGAN, BA
    RANCE, MJ
    SMITH, CFC
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1981, 70 (04) : 531 - 540
  • [9] PREPARATION OF IODINE-131 LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC ACTIVITY
    HUNTER, WM
    GREENWOOD, FC
    [J]. NATURE, 1962, 194 (4827) : 495 - &
  • [10] ILLES P, 1985, J PHARMACOL EXP THER, V232, P526